Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Introduction
- Scope and Methodology
- Size and Growth of the Market
- Issues an Trends Affecting Market
- Leading Competitors
CHAPTER TWO: INTRODUCTION
- Introduction to Multiple Sclerosis
- Progression of Multiple Sclerosis
- Relapsing-remitting MS
- Primary-progressive MS
- Secondary-progressive MS
- Progressive-relapsing MS
- Benign MS
- Pathogenesis of MS
- Inflammatory Response and MS
- Triggers
- Risk Factors
- Physical Complications of MS
- Diagnosing MS
- Demographics and Statistics
CHAPTER THREE: TREATMENTS FOR MULTIPLE SCLEROSIS
- Description of Products
- Copaxone
- Avonex
- Rebif
- Betaferon/Betaseron
- Tysabri
- Novantrone
- Research and Development
- Late Stage Development
- Early to Mid Stage Development
- Phase II Development
- Phase I Development
- Preclinical Development and Research
- Experimental Drugs and Treatments
- Discontinued Development
- Market and Competitive Analysis
- World Market Analysis
- World Competitive Analysis
- Markets by World Region
- U.S. Market
- Europe Market
- Japan Market
CHAPTER FOUR: ISSUES AND TRENDS AFFECTING THE MS MARKET
- Introduction
- Medicare and Health Insurance Issues
- NIH MS Funding Reduction
- Stem Cell Controversy and MS
- Access to Life-Saving Medicine Act and MS
- Par-3 Discovery
- Cyclophilin D Regulation
- Women and MS
- Pregnancy and MS
- Alternative Therapies in MS Treatment
- MS and Diabetes
CHAPTER FIVE: COMPANY PROFILES
- Bayer Schering Pharma AG
- Biogen IDEC
- Novartis AG
- Sanofi-Aventis
- Merck Serono S.A.
- Teva Pharmaceutical Industries Ltd
- APPENDIX: COMPANY NAMES AND ADDRESSES
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Table 1-1: Multiple Sclerosis Cases in Selected Countries.
- Table 1-2: The Worldwide Multiple Sclerosis Market 2004-2011
- Figure 1-1: The Worldwide Multiple Sclerosis Market 2004-2011
CHAPTER TWO: INTRODUCTION
- Table 2-1: Estimated World Prevalence of Multiple Sclerosis by Selected
Countries
- Figure 2-1: Estimated World Prevalence of Multiple Sclerosis by Selected
Countries
- Table 2-2: World Population by Selected Geographical Region, 2006-2050
- Figure 2-2: World Population by Selected Geographical Region, 2006-2050
- Table 2-2: World Population by Selected Countries, 2006
- Figure 2-3: World Population by Selected Countries, 2006
- Table 2-3: Estimated World Population by Age, sex and Geographical Region,
2006
- Figure 2-4: Estimated World Population by Age and Geographical Region, 2006
- Figure 2-5: Estimated World Population by Sex and Geographical Region, 2006
CHAPTER THREE: TREATMENTS FOR MULTIPLE SCLEROSIS
- Table 3-1: Currently Available Multiple Sclerosis
- Treatments (Brand Name, Generic Name, Marketer and Approval Dates)
- Table 3-2: Estimated World Sales for Leading Products, 2004-2006
- Figure 3-1: Estimated World Sales for Leading Products, 2006
- Figure 3-2: Estimated World Sales for Leading Products 2004-2006
- Figure 3-3: Estimated World Sales for Leading Products, 2006
- Table 3-3: Multiple Sclerosis Products in Late Stage Development
- Table 3-4: Multiple Sclerosis Products in Early to Mid-Stage Development
- Table 3-5: The Worldwide Multiple Sclerosis Market 2004-2011
- Figure 3-4: The Worldwide Multiple Sclerosis Market 2004-2011
- Table 3-6: The Worldwide Multiple Sclerosis Market Estimated Revenues and
Market Share of Leading Suppliers 2006
- Figure 3-5: The Worldwide Multiple Sclerosis Market Estimated Market Share
by Leading Suppliers 2001
- Table 3-7: The Worldwide Multiple Sclerosis Market Projected Revenues and
Market Share of Leading Suppliers 2011
- Figure 3-6: The Worldwide Multiple Sclerosis Market Projected Market Share
by Leading Suppliers 2011
- Table 3-8: The Worldwide Multiple Sclerosis Market Estimated Products
Sales by Geographic Region, 2004-2006
- Figure 3-7: The Worldwide Multiple Sclerosis Market Estimated Products
Sales by Geographic Region, 2004-2006
- Figure 3-8: The Worldwide Multiple Sclerosis Market Estimated Products
Sales by Geographic Region, 2004
- Figure 3-9: The Worldwide Multiple Sclerosis Market Estimated Products
Sales by Geographic Region, 2005
- Figure 3-10: The Worldwide Multiple Sclerosis Market Estimated Products
Sales by Geographic Region, 2006
- Table 3-9: The U.S. Multiple Sclerosis Market Estimated Revenues and
Market Share of Leading Suppliers 2006
- Figure 3-13: The U.S. Multiple Sclerosis Market Projected Market Share by
Leading Suppliers 2006
- Table 3-10: The European Multiple Sclerosis Market Estimated Revenues and
Market Share of Leading Suppliers 2006
- Figure 3-14: The European Multiple Sclerosis Market Projected Market Share
by Leading Suppliers 2006
- Table 3-11: The Japanese Multiple Sclerosis Market Estimated Revenues and
Market Share of Leading Suppliers 2006
- Figure 3-15: The Japanese Multiple Sclerosis Market Projected Market Share
by Leading Suppliers 2006
CHAPTER FOUR: ISSUES AND TRENDS AFFECTING THE MS MARKET
- Table 4-1: NIH Funding By Year
|
Related Report
|
View Cart
